Pharmabiz

Molecular profiling is changing cancer treatment in India: Dr Raman Narang

Molecular profiling is changing cancer treatment in India. It helps in examining specific biomarkers, genes and other ...
Pharmabiz

DTAB revises recommendation on exemption for requirement of wholesale license for liquid antiseptic in Schedule K

DTAB revises recommendation on exemption for requirement of wholesale license for liquid antiseptic in Schedule K: Gireesh Babu, New Delhi Saturday, September 26, 2026, 08:00 Hrs ...
Pharmabiz

IPM registers double-digit growth in August as chronic segment outpaces acute market

IPM registers double-digit growth in August as chronic segment outpaces acute market: Peethaambaran Kunnathoor, Chennai Saturday, September 26, 2026, 08:00 Hrs [IST] The Indian Ph ...
Pharmabiz

Indian pharmacies stand firm on transparency & accountability in drug expiry & patient safety

Indian pharmacies stand firm on transparency & accountability in drug expiry & patient safety: Nandita Vijayasimha, Bengaluru Saturday, September 26, 2026, 08:00 Hrs [IST] Indian ...
Pharmabiz

Healthcare and medtech sectors will create opportunities for innovation and collaboration: Falgun Jani

Healthcare and medtech sectors will create opportunities for innovation and collaboration: Falgun Jani: Yash Ved, Mumbai Saturday, September 26, 2026, 08:00 Hrs [IST] The healthca ...
Pharmabiz

Astellas begins patient dosing in phase 3 study of setidegrasib in previously treated KRAS G12D- mutated advanced non-small cell lung cancer

Astellas begins patient dosing in phase 3 study of setidegrasib in previously treated KRAS G12D- mutated advanced non-small cell lung cancer: Tokyo Friday, September 25, 2026, 14: ...
Pharmabiz

Natera’s Signatera test receives Japan’ PMDA approval as a companion diagnostic in muscle-invasive bladder cancer

Natera’s Signatera test receives Japan’ PMDA approval as a companion diagnostic in muscle-invasive bladder cancer: Austin, Texas Friday, September 25, 2026, 17:00 Hrs [IST] Na ...
Pharmabiz

Honeywell report reveals gaps in industry’s OT cybersecurity protection despite rising AI-enabled critical infrastructure threats

Honeywell report reveals gaps in industry’s OT cybersecurity protection despite rising AI-enabled critical infrastructure threats: Our Bureau Bengaluru Friday, September 25, 202 ...
Pharmabiz

US FDA Advisory Committee recommends marketing approval of GRAIL’s Galleri multi-cancer early detection test

US FDA Advisory Committee recommends marketing approval of GRAIL’s Galleri multi-cancer early detection test: Sunnyvale, California Friday, September 25, 2026, 15:00 Hrs [IST] G ...
Pharmabiz

Gossamer Bio submits NDA to US FDA for seralutinib to treat pulmonary arterial hypertension

Gossamer Bio submits NDA to US FDA for seralutinib to treat pulmonary arterial hypertension: San Diego Friday, September 25, 2026, 16:00 Hrs [IST] Gossamer Bio, Inc., a clinical-s ...
Pharmabiz

Alexion advances pioneering leadership in gMG care with data at 2026 AANEM Annual Meeting and MGFA Scientific Session

Alexion advances pioneering leadership in gMG care with data at 2026 AANEM Annual Meeting and MGFA Scientific Session: Cambridge, UK Friday, September 25, 2026, 11:00 Hrs [IST] Al ...
Pharmabiz

NIH funded study shows modified HIV drug reverses vision loss and paralysis in multiple sclerosis model

NIH funded study shows modified HIV drug reverses vision loss and paralysis in multiple sclerosis model: Bethesda, Maryland Friday, September 25, 2026, 12:00 Hrs [IST] A new Natio ...